BSE filing, NSE: INTEGFD. Summary written from the filing by ALFA Finder's alert engine.
Integrated Proteins Ltd: key numbers
- Share price
- ₹13.08
- Market cap
- ₹244.8 Cr
- Revenue (annual)
- ₹9.94 Cr
- Net profit (annual)
- ₹0.22 Cr
- P/E (TTM)
- 389.3×Sector 38.3×
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Integrated Proteins Ltd
All →Integrated Proteins Other Announcement
Integrated Proteins Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI regulations.
Integrated Proteins Management Change
Integrated Proteins Limited appointed Sandeep Mahadik as Non-Executive Independent Director and Ankita Shah as Secretarial Auditor, both effective September 30, 2026.
Integrated Proteins Annual General Meeting
Integrated Proteins Ltd held its Annual General Meeting on September 30, 2026. Shareholders considered resolutions regarding financial statements and company appointments.
Integrated Proteins Annual General Meeting
Integrated Proteins Ltd has announced its 33rd Annual General Meeting scheduled for September 30, 2026, via video conferencing to transact business including financial statement adoption.
Integrated Proteins Annual Report
Integrated Proteins Limited has released its 33rd Annual Report for the financial year 2025-26, containing financial statements and details for the upcoming annual general meeting.
Integrated Proteins Capital Structure Change
Integrated Proteins Limited has been assigned a new ISIN, INE177M01021, following a stock split. The change is effective from September 4, 2026.
Other other announcement announcements
All →Mahindra & Mahindra Financial Services Other Announcement
Mahindra & Mahindra Financial filed its ALM statement as of September 30, 2026, submitted to RBI. It is a periodic regulatory return with no new transaction.
ACME Solar Holdings Other Announcement
ACME Solar filed the CARE Ratings monitoring agency report on its Rs.2,800 crore QIP for the quarter ended 30 September 2026. The report shows no deviation from the offer objects.
eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.